Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Condition: Opioid-use Disorder Interventions: Drug: Buprenorphine/naloxone; Drug: Placebo Sponsors: New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials